Issue |
E3S Web of Conf.
Volume 553, 2024
2024 International Conference on Ecological Protection and Environmental Chemistry (EPEC 2024)
|
|
---|---|---|
Article Number | 05046 | |
Number of page(s) | 4 | |
Section | Medical Treatments and Therapies | |
DOI | https://doi.org/10.1051/e3sconf/202455305046 | |
Published online | 24 July 2024 |
CRISPR-Cas9 in cancer therapy: Revolutionizing oncology through targeted gene editing
Northeast Agricultural University, Biological Science Department, 150000, Harbin, China
* Corresponding author: jjones62270@student.napavalley.edu
One of the major illnesses that poses a substantial threat to people’s health is cancer, and finding medical research has always placed a lot of emphasis on efficient and feasible techniques. CRISPR-Cas9 gene editing technology has characteristics of simplicity, efficiency and strong targeting. It can treat some difficult diseases with gene basis, especially cancer by editing DNA sequences, and has great potential for development in tumor treatment. Some technologies have entered the clinical human experimental stage. The review mainly provides an overview of gene editing technology, CRIPSR-Cas9 system, and its research in tumor treatment, exploring the problems it faces in clinical treatment, and providing prospects for the future application of this technology in tumor treatment.
© The Authors, published by EDP Sciences, 2024
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.